IRISanRaf

BARBANTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.396
AS - Asia 2.116
EU - Europa 560
SA - Sud America 144
Continente sconosciuto - Info sul continente non disponibili 67
AF - Africa 38
OC - Oceania 13
Totale 6.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.942
TR - Turchia 1.052
SG - Singapore 464
CA - Canada 439
CN - Cina 413
IT - Italia 162
BR - Brasile 126
IE - Irlanda 71
EU - Europa 65
UA - Ucraina 63
IN - India 60
GB - Regno Unito 47
RU - Federazione Russa 45
DE - Germania 44
HK - Hong Kong 33
FI - Finlandia 28
ES - Italia 20
NL - Olanda 19
SC - Seychelles 16
JP - Giappone 14
VN - Vietnam 14
MX - Messico 12
BD - Bangladesh 11
FR - Francia 11
AU - Australia 10
SE - Svezia 9
EG - Egitto 7
PK - Pakistan 7
PL - Polonia 7
ZA - Sudafrica 7
CL - Cile 6
IL - Israele 6
IR - Iran 5
RO - Romania 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
KE - Kenya 4
SA - Arabia Saudita 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
ID - Indonesia 3
IQ - Iraq 3
KR - Corea 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AR - Argentina 2
AT - Austria 2
CO - Colombia 2
DZ - Algeria 2
EC - Ecuador 2
HR - Croazia 2
MN - Mongolia 2
MT - Malta 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
HN - Honduras 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
OM - Oman 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.334
Salva come PNG Salva come JPEG
Città #
Kocaeli 926
San Mateo 664
Toronto 421
Dallas 330
Wilmington 223
Santa Clara 187
Houston 181
Singapore 165
Lawrence 140
Princeton 140
Ashburn 126
Beijing 102
Fairfield 74
Los Angeles 59
Seattle 54
Chandler 49
West Jordan 46
Redwood City 43
Shanghai 38
Woodbridge 34
Hong Kong 31
Rome 30
Brooklyn 29
New York 29
Guangzhou 26
Cambridge 24
Dublin 24
Helsinki 24
São Paulo 24
Milan 15
Shenzhen 13
Vicenza 13
Munich 11
Suffern 10
Tokyo 10
Chicago 9
Council Bluffs 9
London 9
Saint Petersburg 8
San Francisco 8
Andover 7
Atlanta 7
Boston 7
Charlotte 7
Ho Chi Minh City 7
Rui'an 7
Secaucus 7
The Dalles 7
Wuhan 7
Ankara 6
Mexico City 6
Philadelphia 6
St Petersburg 6
Warsaw 6
Washington 6
Wuxi 6
Ann Arbor 5
Borås 5
Hanoi 5
Jiaxing 5
Johannesburg 5
Montreal 5
Pune 5
Quanzhou 5
Xi'an 5
Buffalo 4
Columbus 4
Curitiba 4
Denver 4
Fontebuona 4
Nairobi 4
Nanjing 4
Nantong 4
Phoenix 4
Pittsburgh 4
Redmond 4
Sanming 4
Amsterdam 3
Carol Stream 3
Chennai 3
Dhaka 3
Dongyang 3
Florence 3
Gatchina 3
Kansas City 3
Karachi 3
Kiev 3
Kyiv 3
Lisbon 3
Malo 3
Manchester 3
Melbourne 3
Miami 3
Moscow 3
Murfreesboro 3
Ottawa 3
Perm 3
Poplar 3
Rio De Janeiro 3
Rockville 3
Totale 4.625
Salva come PNG Salva come JPEG
Nome #
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 120
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 104
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 97
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 93
A case-control study on excessive daytime sleepiness in chronic migraine 81
A case - control study on excessive daytime sleepiness in episodic migraine 80
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 78
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 77
A case-control study on excessive daytime sleepiness in chronic migraine 75
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 66
Unilateral cranial autonomic symptoms in migraine 59
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 58
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 56
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 55
Ketogenic diet in migraine: rationale, findings and perspectives 54
Late motor recovery is influenced by muscle tone changes after stroke 54
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 54
Acupuncture in cluster headache: Four cases and review of the literature 54
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 53
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 53
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 52
Acute pathological laughter induced by sumatriptan 51
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 51
Dopamine hypersensitivity in migraine: Role of the apomorphine test 51
Dopamine and migraine: Does Parkinson's disease modify migraine course? 51
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 51
Tardive dyskinesias in the elderly 51
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 51
A mechanism-based classification of pain in multiple sclerosis 50
Treatment of tension-type headache: from old myths to modern concepts 50
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 50
Machine learning approach to predict medication overuse in migraine patients 50
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 49
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 49
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 49
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 49
Cluster headache: management of acute attacks before triptans 49
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 48
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 48
Migraine and movement disorders 48
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 48
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 48
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 47
Donepezil in the treatment of progressive supranuclear palsy 47
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 47
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 47
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 46
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 46
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 46
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 46
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 46
Real-world insights on the management of migraine patients: an Italian nationwide study 46
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 45
Tension type headache: a neuropsychological and neurophysiological study 45
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 44
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 44
Migraine and the extrapyramidal system 44
Migraine attack delays gastric emptying: an ultrasonographic study 43
Shortened cortical silent period in facial muscles of patients with migraine 43
Drugs targeting nitric oxide synthase for migraine treatment 43
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 43
Hypertension as a risk factor for migraine chronification 43
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 42
Trigeminal sensory pathway function in patients with SUNCT 42
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 42
Restless legs syndrome is not associated with migraine with aura: a clinical study 42
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 42
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 41
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 41
Use of dopamine agonists in aged patients with Parkinson's disease 41
Impairment of trigeminal sensory pathways in cluster headache 41
Unilateral Cranial Autonomic Symptoms in Migraine: A Retrospective Case Series on 757 Patients 41
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 40
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 40
A proposal for a national registry on chronic migraines 40
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 39
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 39
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 39
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 39
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 39
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 39
Biomarkers in Migraine Headache: Prognostic and Therapeutic Implications 39
Migraine as a Cortical Brain Disorder 39
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 38
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 38
CEP Cortelli Corrigendum for 515342 (vol 34, pg 434, 2014) 38
Future trends in drugs for migraine prophylaxis 38
Excessive daytime sleepiness in untreated Parkinson's disease patients: Follow-up after 1 year of dopaminergic drug therapy 38
Headache in chronic cocaine users: A cross-sectional study 38
The role of dopamine in migraine 38
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 37
Symptomatic cluster headache following an ischaemic lesion of the trigemino-cervical complex 37
Rational for using SSRI (selective serotonin uptake inhibitors) in migraine prophylaxis 37
Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies 36
Migraine prophylaxis: what is new and what we need? 36
Role of neurostimulation in migraine 36
Migraine and Tourette syndrome 36
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire 36
Pharmacotherapy for acute migraines in children and adolescents 36
Redox mechanisms in migraine: novel therapeutics and dietary interventions 35
Totale 4.891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.384 0 0 26 16 49 78 58 35 47 73 940 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/2026706 259 356 91 0 0 0 0 0 0 0 0 0
Totale 6.566